| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/01/2004 | WO2003031940A3 Structural and cytoskeleton-associated proteins |
| 04/01/2004 | WO2003029405A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 04/01/2004 | WO2003027328A3 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid |
| 04/01/2004 | WO2003023362A3 Methods of ameliorating arthritis by modulating jnk signalsome activity |
| 04/01/2004 | WO2003019141A3 Analysis of circulating tumor cells, fragments, and debris |
| 04/01/2004 | WO2003016563A3 Novel molecular target for neurotoxicity |
| 04/01/2004 | WO2003016492A3 Adamts13 genes and proteins and variants, and uses thereof |
| 04/01/2004 | WO2002097047A3 Compositions and methods for the inference of pigmentation traits |
| 04/01/2004 | WO2002095416A8 Method for identifying micro-organisms using mass spectrometry |
| 04/01/2004 | WO2002083847A3 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2004 | WO2002072870A3 Dry solid medium for storage and analysis of genetic material |
| 04/01/2004 | WO2002072006A9 METHODS AND REAGENTS FOR IDENTIFYING COMPOUNDS AND MUTATIONS THAT MODULATE DOPAMINE β-HYDROXYLASE ACTIVITY |
| 04/01/2004 | WO2002064631A3 T1r taste receptors and genes encoding same |
| 04/01/2004 | WO2002059377A3 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 04/01/2004 | WO2002058637A9 Compositions and methods for diagnosis of neuropsychiatric disorders |
| 04/01/2004 | US20040064848 Comprises nucleotide sequences coding dehydroquinase/shikimate dehydrogenase for use in high throughput assay which detects herbicides |
| 04/01/2004 | US20040064843 Process for estimating random error in chemical and biological assays |
| 04/01/2004 | US20040064246 Wheel lift identification for an automotive vehicle using passive and active detection |
| 04/01/2004 | US20040063923 Molecular differences between species of the M. tuberculosis complex |
| 04/01/2004 | US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063906 Peptide nucleic acid sequences; antibodies for controlling disease; bactericides, viricides |
| 04/01/2004 | US20040063905 Armed peptides |
| 04/01/2004 | US20040063758 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate |
| 04/01/2004 | US20040063656 Detecting missense mutation with oligonucleotide probe; hereditary lymphedema |
| 04/01/2004 | US20040063638 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063632 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 04/01/2004 | US20040063213 Pretreatment; using tetrazolium compound and polyoxyethylene glycol surfactant; accuracy measurement |
| 04/01/2004 | US20040063207 Recombinational cloning using nucleic acids having recombination sites |
| 04/01/2004 | US20040063198 Point source biological agent detection system |
| 04/01/2004 | US20040063197 Apparatus which utilizes polymerase chain reactions to detect aerosolized biological agent in air and on abjects |
| 04/01/2004 | US20040063196 Microfluidic apparatus for dielectric and optical manipulation of suspended particles, such as, proteins, DNA and cells |
| 04/01/2004 | US20040063191 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 04/01/2004 | US20040063189 Bacteriophages that infect bacillus bacteria (anthrax) |
| 04/01/2004 | US20040063180 Comprises nucleotide sequences coding lysine biosynthetic polypeptide for transforming coryneform bacteria and fermentation of lysine; animal feeds and medicine |
| 04/01/2004 | US20040063168 System and method for analyzing antibiotic susceptibility of biological samples |
| 04/01/2004 | US20040063167 Minimising calibration problems of in vivo glucose sensors |
| 04/01/2004 | US20040063165 Light-activated in vitro assay process for luciferase bioluminescence |
| 04/01/2004 | US20040063162 Using fluorescent reporter molecules and optical analysis to identify cell undergoing cellular hypertrophy; drug design and screening; gene therapy |
| 04/01/2004 | US20040063156 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 04/01/2004 | US20040063155 Using subtilisin to target preferential nucleotide sequences and diagnose viral and parasitic infections |
| 04/01/2004 | US20040063149 Method of identifying abnormal immune reactions |
| 04/01/2004 | US20040063148 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity |
| 04/01/2004 | US20040063144 Multiple displacement amplification |
| 04/01/2004 | US20040063142 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/01/2004 | US20040063140 Methods for diagnosis of cancer using erbB-3 |
| 04/01/2004 | US20040063139 Comprises using nucleotide sequences coding deoxyguanosine triphosphate triphosphophydrolase to detect microorganisms in water supply |
| 04/01/2004 | US20040063138 Polynucleotide sequencing method |
| 04/01/2004 | US20040063137 Using fluorescent emission to quantify and analyze polymorphisms in nucleotide sequences |
| 04/01/2004 | US20040063135 Comprises oligonucleotides for determining concentration of glucuonidase in cell culture; detection and monitoring of malignancies and metastasis; targeted drug delivery |
| 04/01/2004 | US20040063134 Novel isoforms of human pregnancy-associated protein-E |
| 04/01/2004 | US20040063133 Method of normalizing gene expression data |
| 04/01/2004 | US20040063126 Electrochemical sensor using intercalative, redox-active moieties |
| 04/01/2004 | US20040063125 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 04/01/2004 | US20040063124 Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| 04/01/2004 | US20040063123 Using allelic mutation in defensin genes to diagnose and prognose oral disorders |
| 04/01/2004 | US20040063122 Method for separating and purifying a nucleic acid |
| 04/01/2004 | US20040063119 Evaluating transcription associated with sponges and other metazoans in culture; bioreactors for medicinal products |
| 04/01/2004 | US20040063112 Using template to prepare imprinted frozen fluid usable as separation medium, recognition element in sensors and bioassays and as catalyst |
| 04/01/2004 | US20040063111 Method for protecting personal information |
| 04/01/2004 | US20040063110 Novel probes for the detection of mycobacteria |
| 04/01/2004 | US20040063109 Apparatus for monitoring allelic discrimination and/or gene expression analysis and subsequent storage on computer medium |
| 04/01/2004 | US20040063108 Methods of diagnosis of colorectal cancer, compositions and methods of screening for modulators of colorectal cancer |
| 04/01/2004 | US20040063107 Novel proteases |
| 04/01/2004 | US20040063106 Biopolymeric array scanning devices that focus on the far side of an array and methods for using the same |
| 04/01/2004 | US20040063105 Using spectrum analysis of solid support to identify, evaluate and detect target genes, mutations and allelic variation in biological sample; optical detection system and proteomics |
| 04/01/2004 | US20040063104 Methods and compositions for producing labeled probe nucleic acids for use in array based comparative genomic hybridization applications |
| 04/01/2004 | US20040063103 Detection of mecA-containing Staphylococcus spp. |
| 04/01/2004 | US20040063102 Genetic marker and test |
| 04/01/2004 | US20040063101 Comprises nucleotide sequences coding cancer/testis (CT) antigen for diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 04/01/2004 | US20040063097 Nanomachine compositions and methods of use |
| 04/01/2004 | US20040063096 Oligonucleotides and method for characterizing and detecting genogroup II type small round structured virus |
| 04/01/2004 | US20040063095 gM-negative EHV-mutants |
| 04/01/2004 | US20040063093 Recombinant feline coronavirus S proteins |
| 04/01/2004 | US20040063091 Detecting presence or absence of DNA viruses in biological sample; diagnosis, treatment and prevention of viral disease |
| 04/01/2004 | US20040063090 Method for quantification of recombinant viruses |
| 04/01/2004 | US20040063089 Device which utilizes optical analysis identify modulators of arrhythmia, hypertension and diabetes; drug screening |
| 04/01/2004 | US20040063088 Analyzing effect of antitumor agents on tumorous breast tissue |
| 04/01/2004 | US20040062769 Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A |
| 04/01/2004 | US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 04/01/2004 | US20040062759 Polymeric patch containing enzyme; absorber |
| 04/01/2004 | US20040062687 Biosynthetic pathway with immobilized enzymes or biocatalysts |
| 04/01/2004 | US20040061841 Enzyme electrodes and method of manufacture |
| 04/01/2004 | US20040061049 Determinat in-focus-distance for position on surface of biopolymeric array; detecting signal and filtration; data processing |
| 04/01/2004 | US20040060818 Small volume in vitro analyte sensor and methods of making |
| 04/01/2004 | US20040060568 Hedgehog antagonists, methods and uses related thereto |
| 04/01/2004 | DE202004000946U1 Apparatus for determining the antibiotic resistance of bacteria includes an underlay in the form of a reader template having a system for interpreting antibiotic-induced zones of inhibition |
| 04/01/2004 | DE10244129A1 Identifying active agent complexes that modify proton pump proteins, useful as pharmaceuticals, from their effect on the potential at an electrode that carries the protein |
| 04/01/2004 | DE10243131A1 Verfahren zur Unterscheidung von Chondrozyten, die in der Lage sind, eine extrazelluläre knorpelige Matrix auszubilden, von Chondrozyten, die diese Fähigkeit nicht besitzen, durch Bestimmung des Genexpressionsstatus A method for distinguishing of chondrocytes, which are capable of forming an extracellular cartilage matrix, chondrocytes that do not have this ability, by determining the gene expression status |
| 04/01/2004 | CA2505410A1 Method for determining the predisposition of patients to toxicity or lack of efficacy of a drug |
| 04/01/2004 | CA2499995A1 Compositions and methods for treatment of herpesvirus infections |
| 04/01/2004 | CA2499685A1 The use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity |
| 04/01/2004 | CA2499644A1 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof |
| 04/01/2004 | CA2499537A1 Method of determining specific groups forming heparins or low-molecular-weight heparins |
| 04/01/2004 | CA2499527A1 An analyzer for the simultaneous enzymatic detection of closely related analytes |
| 04/01/2004 | CA2499390A1 Kits and methods for assessing skin health |
| 04/01/2004 | CA2499383A1 Method for assaying compounds that decrease the activity of poly(adp-ribose)-polymerase (parp) |
| 04/01/2004 | CA2499360A1 Methods and compositions for detecting targets |
| 04/01/2004 | CA2499077A1 Methods and composition for detecting targets |
| 04/01/2004 | CA2498764A1 Helicase dependent amplification of nucleic acids |
| 04/01/2004 | CA2498713A1 Real-time detection of nucleic acid reactions |